Global Artificial Intelligence in Drug Discovery Market (2021 to 2028) – Share, Size, Trends and Industry Analysis Report – ResearchAndMarkets.com

Global Artificial Intelligence in Drug Discovery Market (2021 to 2028) – Share, Size, Trends and Industry Analysis Report – ResearchAndMarkets.com




Global Artificial Intelligence in Drug Discovery Market (2021 to 2028) – Share, Size, Trends and Industry Analysis Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Application; By Regions; Segment Forecast, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering.

The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.

Artificial intelligence (AI) platforms are designed to ascertain genetic mutations, helping oncologists in designing effective treatment plans. In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.

However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.

For instance, artificial intelligence (AI)-based drug discovery company, Existencia, entered into an agreement with Scripps Research to identify COVID-19 antiviral therapies. On the same ground, Google’s Deepmind company also working on the artificial intelligence (AI) platform AlphaFold. The product is designed to provide information on several proteins involved in the diagnosis of SARS and COVID-19.

Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.

In this direction, in January 2021, the US-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology

4. Artificial Intelligence in Drug Discovery Market Insights

5. Artificial Intelligence in Drug Discovery Market Assessment by Application

6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area

7. Artificial Intelligence in Drug Discovery Market Assessment by Geography

7.1. Key findings

7.2. Introduction

7.3. Artificial Intelligence in Drug Discovery Market – North America

7.4. Artificial Intelligence in Drug Discovery Market – Europe

7.5. Artificial Intelligence in Drug Discovery Market – Asia-Pacific

7.6. Artificial Intelligence in Drug Discovery Market – Middle East & Africa

7.7. Artificial Intelligence in Drug Discovery Market – Latin America

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis

8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. IBM Watson

9.2. Exscientia

9.3. GNS Healthcare

9.4. Alphabet (DeepMind)

9.5. Benevolent AI

9.6. BioSymetrics

9.7. Euretos

9.8. Berg Health

9.9. Atomwise

9.10. Cyclica

For more information about this report visit https://www.researchandmarkets.com/r/5lpdmc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900